|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.85 SEK | -0.85% |
|
+9.21% | -2.88% |
| Jul. 07 | SEB Lowers Swedencare Target Price to 49 Kronor (52), Reiterates Buy - BN | FW |
| Jul. 01 | Pareto Securities' Swedish Portfolio Outperforms Index, Implements Two Changes for July | FW |
| Capitalization | 7.49B 788M 673M 628M 581M 1.08B 67.58B 1.2B 2.86B 31.71B 2.96B 2.9B 116B | P/E ratio 2025 * |
36.9x | P/E ratio 2026 * | 24.8x |
|---|---|---|---|---|---|
| Enterprise value | 8.78B 924M 790M 736M 681M 1.26B 79.25B 1.4B 3.36B 37.18B 3.47B 3.4B 136B | EV / Sales 2025 * |
3.17x | EV / Sales 2026 * | 2.75x |
| Free-Float |
30.51% | Yield 2025 * |
1.09% | Yield 2026 * | 1.54% |
More valuation ratios
* Estimated data
More news
Last Transcript: Swedencare AB
More recommendations
More press releases
| 1 day | -0.85% | ||
| 1 week | +9.21% | ||
| Current month | +8.07% | ||
| 1 month | +9.59% | ||
| 3 months | +36.59% | ||
| 6 months | +5.14% | ||
| Current year | -2.88% |
| 1 week | 42.75 |  | 47.95 |
| 1 month | 39.55 | | 47.95 |
| Current year | 33.2 | | 52.75 |
| 1 year | 33.2 | | 59 |
| 3 years | 22.9 | | 93.94 |
| 5 years | 22.9 | | 159 |
| 10 years | 2.8 | | 159 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2013-12-31 | |
Jenny Graflind
CEO | Chief Executive Officer | 49 | 2019-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 2021-12-31 | |
| Director/Board Member | 58 | 2015-12-31 | |
| Director/Board Member | 62 | 2018-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.85% | +9.21% | -15.51% | -50.13% | 793M | ||
| +0.33% | -0.18% | -8.86% | -10.78% | 70.46B | ||
| +1.76% | +2.17% | +10.91% | -26.45% | 7.34B | ||
| +1.14% | -0.31% | -0.81% | +1.46% | 3.6B | ||
| -0.58% | +9.18% | -0.86% | -8.49% | 3.4B | ||
| +1.37% | +4.29% | +21.88% | -8.39% | 2.33B | ||
| -0.80% | +11.45% | +81.68% | +59.28% | 1.27B | ||
| -0.51% | -1.02% | +47.30% | +9.36% | 1.23B | ||
| +0.78% | +5.58% | -17.09% | -34.90% | 1.06B | ||
| +1.36% | +1.09% | +5.84% | -40.70% | 1.04B | ||
| Average | +0.27% | +3.83% | +12.45% | -10.97% | 9.25B | |
| Weighted average by Cap. | -0.56% | +0.31% | -3.90% | -11.12% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.77B 291M 249M 232M 215M 398M 24.97B 443M 1.06B 11.71B 1.09B 1.07B 42.93B | 3.09B 325M 278M 259M 240M 445M 27.9B 495M 1.18B 13.09B 1.22B 1.2B 47.96B |
| Net income | 197M 20.75M 17.72M 16.52M 15.28M 28.35M 1.78B 31.53M 75.33M 835M 77.85M 76.23M 3.06B | 283M 29.82M 25.48M 23.75M 21.97M 40.74M 2.56B 45.33M 108M 1.2B 112M 110M 4.4B |
| Net Debt | 1.29B 136M 116M 108M 100M 186M 11.67B 207M 494M 5.47B 511M 500M 20.06B | 1.01B 106M 90.86M 84.71M 78.35M 145M 9.12B 162M 386M 4.28B 399M 391M 15.68B |
More financial data
* Estimated data
Employees
587
Sector
Pharmaceuticals
Calendar
Jul. 23
- Q2 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-10 | 46.85 kr | -0.85% | 315,451 |
| 25-07-09 | 47.25 kr | +1.18% | 189,749 |
| 25-07-08 | 46.70 kr | +2.41% | 363,269 |
| 25-07-07 | 45.60 kr | +1.79% | 408,122 |
| 25-07-04 | 44.80 kr | +4.43% | 530,266 |
Delayed Quote Nasdaq Stockholm, July 10, 2025 at 12:00 pm EDT
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
46.85SEK
Average target price
53.67SEK
Spread / Average Target
+14.55%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SECARE Stock
Select your edition
All financial news and data tailored to specific country editions
